HYAL2 and nonpapillary renal cell carcinoma: In addition, an increased number of HA-containing HYAL2+PD-L1+ myeloid-derived suppressor cells (MDSCs) have been observed in ccRCC, promoting HA degradation to LMW-HA, cancer-related inflammation, and immunosuppression132.